Introducing thymus for promoting transplantation tolerance.


Journal

The Journal of allergy and clinical immunology
ISSN: 1097-6825
Titre abrégé: J Allergy Clin Immunol
Pays: United States
ID NLM: 1275002

Informations de publication

Date de publication:
09 2022
Historique:
received: 22 12 2021
revised: 29 04 2022
accepted: 04 05 2022
pubmed: 12 6 2022
medline: 14 9 2022
entrez: 11 6 2022
Statut: ppublish

Résumé

Establishing tolerance remains a central, if elusive, goal of transplantation. In solid-organ transplantation, one strategy for inducing tolerance has been cotransplantation of various forms of thymic tissue along with another organ. As one of the biological foundations of central tolerance, thymic tissue carries with it the ability to induce tolerance to any other organ or tissue from the same donor (or another donor tissue-matched to the thymic tissue) if successfully transplanted. In this review, we outline the history of this approach as well as work to date on its application in organ transplantation, concluding with future directions. We also review our experience with allogeneic processed thymus tissue for the treatment of congenital athymia, encompassing complete DiGeorge syndrome and other rare genetic disorders, and consider whether allogeneic processed thymic tissue implantation may offer a novel method for future experimentation with tolerance induction in organ transplantation.

Identifiants

pubmed: 35690492
pii: S0091-6749(22)00702-3
doi: 10.1016/j.jaci.2022.05.006
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

549-556

Informations de copyright

Copyright © 2022 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.

Auteurs

Zachary W Fitch (ZW)

Department of Surgery, Duke University Medical Center, Durham, NC.

Lillian Kang (L)

Department of Surgery, Duke University Medical Center, Durham, NC.

Jie Li (J)

Department of Surgery, Duke University Medical Center, Durham, NC; Department of Pediatrics, Duke University Medical Center, Durham, NC.

Stuart J Knechtle (SJ)

Department of Surgery, Duke University Medical Center, Durham, NC.

Joseph W Turek (JW)

Department of Surgery, Duke University Medical Center, Durham, NC.

Allan D Kirk (AD)

Department of Surgery, Duke University Medical Center, Durham, NC.

M Louise Markert (ML)

Department of Pediatrics, Duke University Medical Center, Durham, NC; Department of Immunology, Duke University Medical Center, Durham, NC.

Jean Kwun (J)

Department of Surgery, Duke University Medical Center, Durham, NC. Electronic address: jean.kwun@duke.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH